FDA Inspection 635067 — Geritrex Corporation

Geritrex Corporation — FEI 2433753

The FDA completed an inspection of Geritrex Corporation on Dec 14, 2009 in Middletown, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 14, 2009
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Middletown, NY (United States)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented
145621 CFR 211.115(b)Reprocessing/quality control unit
188321 CFR 211.165(a)Testing and release for distribution
355821 CFR 211.52Washing and toilet facilities not provided and accessible